Sponsored Content
New medical nutrition ingredient combines high-protein with “best taste yet"
20 Jan 2025Arla Foods Ingredients has launched Lacprodan® DI-3092, a whey protein hydrolysate designed for peptide-based medical nutrition. It offers 10g of high-quality protein per 100ml, surpassing the market standard. With a better taste profile and minimal bitterness, it addresses key challenges in patient compliance. The product is UHT-stable, low in lactose, and comes in prototypes like a ready-to-drink beverage and powder, both offering a mild taste and low viscosity.
Arla Foods Ingredients has launched a new whey protein hydrolysate with a better taste profile than comparable ingredients for peptide-based medical nutrition.
The highly hydrolysed whey protein ingredient Lacprodan® DI-3092 allows 10g of high-quality single-source protein to be packed into 100ml – significantly higher than the market standard of 6-7g per 100 ml.1 Additionally, it is designed to taste great with minimal bitterness, helping overcome a key challenge in medical nutrition.
Whey protein hydrolysates are produced through an enzymatic process where protein is broken down into peptides. Sometimes described as “pre-digested”, they are a valuable solution for the nutritional needs of patients with impaired gastrointestinal function or nutrient absorption.
However, peptide-based products are also known for an unappealing bitter taste. This is a serious problem given the impact of taste and texture on compliance with medical nutrition. Many patients report that medical drinks have an unpleasant texture and taste,2 and in a recent study, half of those recommended medical nutrition plans did not complete them, or did not take the full dosage.3
Mads Dyrvig, Head of Sales Development, Specialised Nutrition at Arla Foods Ingredients, said: “Whey protein hydrolysates are essential for peptide-based medical nutrition but there are three key challenges in the category. The first is to improve taste and texture, which is important to ensure patient compliance. The second is to go higher in protein, and the third is to do that using a high-quality protein source. Lacprodan® DI-3092 – our best-tasting whey protein hydrolysate yet – overcomes all three challenges.”
To showcase the new product, Arla Foods Ingredients has created two new prototypes – a ready-to-drink beverage and a ready-to-mix powder. Both the 200Kcal recipes contain 10g protein/100 ml and offer a very mild taste, as well as low viscosity.
Lacprodan® DI-3092 offers a high degree of hydrolysis (16-22%) and low lactose content. It is also UHT-stable, making it suitable for both direct and indirect heat treatment.
1 Innova Market Insights
2 Lindberg International, Qualitative study on medical nutrition, 2024
3 FMCG Gurus Medical Nutrition Insights database, 2023
Companies mentioned
Related categories
Related news
PharmaLinea's product awarded for innovation in bone and joint health
11 Mar 2025
>Your< Arthro Ease Capsules received the Annual Bone and Joint Health Award at the Functional Foods for Wellness Summit 2025
Read more
PureGreenLineTM Sustainability and Innovation in Nutraceuticals- is a state-of-the-art-botanical extraction technology
11 Mar 2025
PureGreenLineTM revolutionizes botanical extraction with a cutting-edge, eco-friendly approach that meets the highest standards of quality and purity. Designed for forward-thinking manufacturers, this breakthrough process provides premium extract...
Read more
Your partner in nutraceutical e-commerce
11 Mar 2025
E-commerce has become one of the most prominent sales channels in the dietary supplement market. The convenience of buying them at the click of a button, or even subscribing to receive them periodically, as platforms such as Amazon allow, is an attr...
Read more
ACT strengthens its focus on the animal feed industry with new expert
10 Mar 2025
Atlantic Chemicals Trading GmbH (ACT), an established distributor of raw materials for the food, cosmetics and pharmaceutical industries based in Hamburg, is further expanding its presence in the animal feed sector by hiring Andreas Stein, who bring...
Read more
FERTIBIOME® | EVIDENCIA CLÍNICA (2)
9 Mar 2025
Ligilactobacillus salivarius PS11610 mejora el éxito de la fertilización mediante FIV: un análisis retrospectivo preliminar
Read more
FERTIBIOME® | EVIDENCIA CLÍNICA (1): PAREJAS EN TRATAMIENTO DE REPRODUCCIÓN ASISTIDA
9 Mar 2025
Ligilactobacillus salivarius PS11610 ejerce un efecto sobre el perfil microbiano e inmunológico de parejas con infertilidad desconocida.
Read more
The Power of Vitamin D: Why Consistency Matters
7 Mar 2025
The primary function of vitamin D is to slow down cell division while promoting cell differentiation. When these two effects are combined, vitamin D exhibits an anti-tumor mechanism. Tumors proliferate uncontrollably because their cells lose the a...
Read more
The Truth About Vitamin C: Are You Really Getting Enough?
7 Mar 2025
Your health is in your hands – make Vitamin C a priority today!The Vitamin C is one of the most well-known nutrients, yet most people don’t fully understand its role.The modern diets, stress, and environmental factors impact Vitamin C levels.
Read more
Scientific study shows BENEO’s Palatinose™ as a bedtime drink improves aspects of sleep
7 Mar 2025
A new randomised controlled trial, conducted by Gaylor et al, demonstrates that BENEO’s slow and sustained release carbohydrate Palatinose™ improves aspects of sleep when consumed as a bedtime drink. By leading to more balanced blood glucose level...
Read more
Study shows BENEO’s Palatinose™ stimulates the release of GLP-1 in overweight adults
6 Mar 2025
A new study, led by Prof. Andreas Pfeiffer (Zhang et al.), demonstrates that intake of the naturally sourced, smart carbohydrate Palatinose™ stimulates the release of beneficial gut hormones including GLP-1 in overweight adults, even if its ...
Read more